In a week marked by fluctuations, the benchmark indices, Sensex and Nifty, managed to recover from earlier losses, concluding the week with marginal gains.
The approval granted by the US Food & Drug Administration (US FDA) is for Fluphenazine Hydrochloride tablets of strengths 1 mg, 2.5 mg, 5 mg and 10 mg, Glenmark said in a statement.
On Tuesday, 1992 stocks advanced, 1688 declined and 133 remained unchanged, with an advance decline ratio of 1.18 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.
The company has received approval from the US Food and Drug Administration (USFDA) to market in the US its generic version in strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg, Zydus Cadila said in a statement